Progress in Developing Fibroblast Cell Therapies with FibroBiologics CEO, Pete O'Heeron
FibroBiologics is the leading biotech company focused on developing and commercializing fibroblast cell-based therapies for patients suffering from chronic diseases. In this podcast episode, the Founder and CEO, Pete O'Heeron discusses the promise of fibroblast cell therapy to treat diseases such as multiple sclerosis, degenerative disk disease and more.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.